Currently out of the existing stock ratings of Per Ostlund, 14 are a BUY (93.33%), 1 are a HOLD (6.67%).

Per Ostlund

Work Performance Price Targets & Ratings Chart

Analyst Per Ostlund, currently employed at CRAIG HALLUM, carries an average stock price target met ratio of 69.33% that have a potential upside of 40.05% achieved within 149 days.

Per Ostlund’s has documented 31 price targets and ratings displayed on 5 stocks. The coverage is on the Healthcare sector.

Most recent stock forecast was given on CDNA, Caredx at 06-Jan-2026.

Wall Street Analyst Per Ostlund

Analyst best performing recommendations are on NTRA (NATERA).
The best stock recommendation documented was for NTRA (NATERA) at 11/13/2024. The price target of $157 was fulfilled within 1 day with a profit of $3.97 (2.47%) receiving and performance score of 24.66.

Average potential price target upside

CEMI Chembio Diagnostics CDNA Caredx EXAS EXACT Sciences ICAD icad inc NTRA Natera

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Hold Since 22-Jul-2021

$7.5

4 years 6 months 11 days ago
(22-Jul-2021)

2/2 (100%)

$2.76 (58.23%)

256

Hold Since 03-Dec-2020

$10

$9.54 (2073.91%)

$8

5 years 1 months 30 days ago
(03-Dec-2020)

0/3 (0%)

$2.49 (33.16%)

Buy Since 04-Mar-2020

5 years 7 months 16 days ago
(17-Jun-2020)

2/2 (100%)

$1.27 (34.05%)

162

Buy Since 12-Nov-2019

$12

$11.54 (2508.70%)

5 years 9 months 17 days ago
(16-Apr-2020)

2/2 (100%)

$-0.66 (-5.21%)

83

Show more analysts

Please expand the browser size to see the chart

Which stock is Per Ostlund is most bullish on?

Potential upside of $5.45 has been obtained for CDNA (CAREDX)

What Year was the first public recommendation made by Per Ostlund?

On 2015

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?